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Summary
Increased activity of D2 receptors (D2Rs) in the stria-
tum has been linked to the pathophysiology of schizo-
phrenia. To determine directly the behavioral and
physiological consequences of increased D2R func-
tion in the striatum, we generated mice with reversibly
increased levels of D2Rs restricted to the striatum. D2
transgenic mice exhibit selective cognitive impair-
ments in working memory tasks and behavioral flexi-
bility without more general cognitive deficits. The def-
icit in the working memory task persists even after the
transgene has been switched off, indicating that it re-
sults not from continued overexpression of D2Rs but
from excess expression during development. To de-
termine the effects that may mediate the observed cog-
nitive deficits, we analyzed the prefrontal cortex, the
brain structure mainly associated with working mem-
ory. We found that D2R overexpression in the striatum
impacts dopamine levels, rates of dopamine turnover,
and activation of D1 receptors in the prefrontal cortex,
measures that are critical for working memory.
Introduction
Understanding mental illnesses in terms of molecular al-
terations in specific neural circuitry represents one of
the major challenges for biology and medicine in the
21st century. Unlike neurology, which has been trans-
formed by molecular genetics and by the ability to de-
velop animal models of disease, it has been extremely
difficult to study the molecular biology of mental ill-
nesses and to generate satisfying genetic models, be-
cause, in the case of mental illnesses, we have limited
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the cognitive symptoms of schizophrenia.knowledge of the underlying anatomical, physiological,
and genetic substrates. Indeed, unlike monogenic neu-
rological disorders such as Huntington’s disease, Frag-
ile X, and Rett’s syndrome, the genetics of most mental
illness is polygenic and complex. In neurology, animal
models based on mutations in single genes have proven
to be extremely useful for studying the pathogenesis of
diseases. By contrast, due to the genetic and physiolog-
ical complexity of most mental illnesses, it has not gen-
erally been possible to generate mouse models that ad-
dress all aspects of a psychiatric disease. We therefore
have adopted a more modest strategy in which we focus
on the cognitive deficits of certain mental disorders and
attempt to examine in the mouse the relationship be-
tween a genetic alteration and a specific cognitive com-
ponent of the disorder, an endophenotype.
Dysregulation of dopaminergic neurotransmission
has been associated with multiple neurological and
psychiatric conditions such as Parkinson’s disease, at-
tention deficit hyperactivity disorder (ADHD), mood dis-
orders, and schizophrenia (Goldman-Rakic, 1999; Carls-
son, 2001). Dysfunction of dopamine D2 transmission in
the striatum has been suggested to be an important
component in the pathophysiology of schizophrenia.
All effective antipsychotic drugs antagonize the dopa-
mine D2 receptor (Seeman and Lee, 1975; Creese
et al., 1976), a finding that has provided support for the
original hypothesis formulated by Arvid Carlsson that
excessive dopaminergic transmission is critical in the
pathogenesis of schizophrenia (Carlsson and Lindqvist,
1963). Although the finding of an effective drug target
does not necessarily imply that this target needs to be
involved in the pathophysiology of the disease, addi-
tional evidence has since been accumulated to support
the involvement of striatal D2 receptors. For example,
brain imaging studies have found an increase in the re-
lease of dopamine and in the density and occupancy
of the D2 receptor in the striatum of patients with schizo-
phrenia (Wong et al., 1986; Laruelle et al., 1996; Breier
et al., 1997; Laruelle, 1998; Abi-Dargham et al., 2000;
Seeman and Kapur, 2000). Also, several studies suggest
that at least in a subpopulation of patients the observed
increase in D2 receptor binding may be genetically de-
termined (Hirvonen et al., 2005; Lawford et al., 2005; Hir-
vonen et al., 2004; Zvara et al., 2005).
Although these studies are not without weaknesses,
the thrust of the current evidence suggests a role for
a dopaminergic dysfunction in the pathogenesis of
schizophrenia, although this dysfunction is likely not
the only component. For example, both typical and
atypical antipsychotic drugs that block D2 receptors im-
prove only some of the symptoms. They improve in par-
ticular the positive symptoms, such as hallucinations
and delusions, but have at best modest beneficial ef-
fects on cognitive symptoms such as deficits in working
memory, attentional processesing, and cognitive flexi-
bility (Carpenter and Gold, 2002; Meltzer, 2004; Miya-
moto et al., 2005). Whereas this suggests that D2 recep-
tors in the adult patient are involved in the generation of
positive symptoms (Abi-Dargham et al., 2000; Kapur
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ficult to determine whether the D2 receptors have any
role in the cognitive symptoms.
As a first step in testing a possible causal relationship
between increased D2 receptor density in the striatum
and a cognitive deficit endophenotype, we generated
mice that express increased levels of D2 receptors in
the striatum in a spatially restricted and temporally
controlled manner. Research on the striatum originally
focused on the regulation of locomotion and stimulus-
reward associations, both being modulated by dopami-
nergic inputs from the midbrain. More recently it has
been suggested that the striatum plays a more general
role in learning and cognition and that it may reciprocally
affect cortical processing via striato-pallidal-thalamo-
cortical pathways (reviewed in Graybiel, 2005).
We found that overexpression of D2 receptors selec-
tively in the striatum leads to impairment in tasks that re-
quire working memory and behavioral flexibility. These
deficits persisted even after the transgene was switched
off, indicating that the deficit results from developmen-
tal, not concurrent, functioning of the upregulated D2 re-
ceptors. Importantly, we demonstrated that striatal D2
receptors affect dopamine tissue content, dopamine
turnover, and D1 receptor activation in the prefrontal
cortex, the structure mainly associated with working
memory. These secondary alterations in the prefrontal
cortex may be responsible for the cognitive deficits
observed.
Results
Reversible Overexpression of the Dopamine D2
Receptor mRNA in the Striatum
To achieve striatal-specific D2 receptor overexpression
with temporal regulation, we generated double-trans-
genic mice using the tTA system that express the long
form of the D2 receptor open reading frame (ORF) under
the tetracycline response element tetO. We then
crossed these animals to mice expressing the tetracy-
cline transactivator, tTA, under the CamKIIa promoter
(Mayford et al., 1996) (Figure 1A). Although CamKIIa is
endogenously expressed in the entire forebrain, the
CamKIIa promoter has been used, fortuitously, to target
subregions of the forebrain. We earlier observed that
when crossed to CamKIIa-tTA mice, about 20% of
tetO responder lines give rise to tetO-driven transgene
expression restricted to the striatum and olfactory tu-
bercle (Mayford et al., 1996). Surprisingly, using the D2
receptor ORF, all of the five tetO responder lines that
we generated showed expression restricted to the stria-
tum. Application of doxycycline (40 mg/kg food) for 5
days switches off transgenic D2 receptor mRNA expres-
sion (Figure 1B). In situ hybridization analysis with high
resolution revealed that transgenic mRNA expression
is restricted to the striatum, including the caudate puta-
men, nucleus accumbens, and the olfactory tubercule
(Figures 1C–1H). By counting transgene-positive and
-negative cells, we estimated that within the caudate pu-
tamen and nucleus accumbens 30% and 15% of all cells
express the transgene, respectively. Very few cells in the
hippocampus or neocortex (<<1% of total) express the
transgene. Within the striatum, the CamKIIa promoter
restricts transgenic receptor expression still further toonly the postsynaptic medium spiny neurons and not
to the presynaptic projections from midbrain neurons
of the ventral tegmental area and substantia nigra,
thus affecting the main output neurons of the striatum
(Figure 1B and data not shown).
The Transgenic D2 Receptors Are Functional
Using the D2 receptor antagonist [3H]-methyl-spiper-
one, we performed saturating ligand binding studies
on striatal membrane preparations and found that dou-
ble-transgenic mice have 15% higher receptor binding
capacity than their littermates (Figure 2A, control/trans-
genic: Bmax = 617/706 fmol/mg, Kd = 0.11/0.10 nM; rel
Bmax = 98/113%; t test, p < 0.05, n = 5 3 3 animals per
group). This increase is similar to the calculated 12% in-
crease observed with imaging studies in schizophenic
patients (Laruelle, 1998). This increase in binding capac-
ity was reversible and brought back to basal level after
consumption of doxycycline (40 mg/kg food, Figure 2B
and below, control/transgenic: Bmax = 491/515 fmol/mg,
Kd = 0.05/0.05, rel Bmax = 99.9/104.1%, n = 2 3 5 per
group).
To determine whether these excess receptors are
functional, we measured adenylate cyclase activity in
striatal membrane preparations. We found that basal ac-
tivity is unaffected (Figure 2C, control = 6.413 6 0.60
pmoles cAMP/15 min/mg protein, transgenic = 5.648 6
0.48; t test, p = 0.38, n = 33 3 per group) but that dopa-
mine-induced adenylate cyclase activity is reduced in
D2 receptor transgenic mice (Figure 2D; t test, p < 0.001).
This decrease in activity as a result of excess D2 recep-
tors is consistent with the fact that in the striatum D2 re-
ceptors are coupled to G proteins that inhibit the activity
of adenylate cyclase.
Mice Overexpressing D2 Receptors in the Striatum
Show Unaltered Locomotor Activity, Sensorimotor
Gating, and Generalized Anxiety
Striatal dopamine receptors affect locomotion; we
therefore measured locomotor activity and stereotypic
behavior in control and D2 receptor transgenic mice.
We found no significant differences between the geno-
types, although the transgenic mice showed a trend
toward less activity (Figure 3A; total path-length: trans-
genic = 177.4 6 11.1 cm, control = 219 6 14.0 cm;
ANOVA, p = 0.33; stereotypic time: transgenic = 586.0 6
20.3 s, control = 625.0 6 24.6 s; ANOVA, p = 0.65, n =
17 per genotype). Also, latencies to complete maze
tasks were not affected by excess of D2 receptors.
Sensorimotor gating deficits are observed in schizo-
phrenic patients, their first-degree relatives, as well as
in patients with other schizotypal disorders (reviewed
by Braff et al., 2001). To measure sensory gating, we
used prepulse inhibition (PPI), whereby a weak prepulse
stimulus attenuates the response to a subsequent star-
tling stimulus. We found no differences in the attenua-
tion of the response to the acoustic stimulus after the
prepulse (Figure 3B; n = 12/10). The magnitude of startle
response to the acoustic stimulus was also unaffected
(control = 870 lbs/m2/s, transgenic = 929 lbs/m2/s for
P120 dB; p > 0.5), as was habituation to the acoustic
stimulus (ANOVA, p > 0.5).
Differences in anxiety levels can affect performance
in cognitive tasks; we therefore measured anxiety by
Excess Striatal D2 Receptors Affect PFC Function
605Figure 1. Reversible Overexpression of the Dopamine D2 Receptor mRNA in the Striatum
(A) (Left) Construct used to express the tetracycline transactivator, tTA. The transactivator is driven by the 8.5 kb upstream promoter region of the
CamKIIa gene. SV40pA, Simian Virus 40 late polyadenylation signal. (Right) Construct used to express the D2 receptor under tTA control. The
tetO promoter consists of seven operator sequences of the E. coli Tn 10 tetracycline resistance operon and a Cytomegalus Virus minimal pro-
moter. hGHpA, 2.1 kb of the human growth hormone gene harboring the hGH polyadenylation signal.
(B) Expression of transgenic D2 receptor mRNA is restricted to the striatum and is regulated by doxycycline application as shown via in situ
hybridization. Gene off, transgenic expression is switched off after 5 days of doxycycline application (40 mg/kg food).
(C–H) Transgene expression is restricted to the striatum. Fresh frozen cryostat sections (20 mm) were hybridized with a riboprobe against the
hGHpA mRNA. (C) Control and (D) D2R mouse at the level of the striatum (203), (E) D2R mouse at the level of PFC (203), Cx, cortex; CPu, caudate
putamen; NAc, nucleus accumbens; Tu, olfactory tubercle.
(F) Transgene expression in the hippocampus (1003).
(G) Approximately 30% of striatal cells express transgenic mRNA (4003).
(H) Transgene expression in the medial PFC (1003).testing the mice on an elevated plus maze and found no
effect of genotype on the ratio of time spent in the closed
and open arms (Figure 3C, n = 17 per group). We also de-
termined that D2 receptor mice spent the same percent-
age of time in the center of an open-field arena than con-
trol mice (D2 receptor transgenic = 11.8% 6 2.6%,
controls = 11.5% 6 2.3%; t test, p = 0.93).Mice Overexpressing D2 Receptors in the Striatum
Display Deficits in Working Memory Tasks
and Behavioral Flexibility
Neuropsychological studies of patients with schizo-
phrenia have consistently identified deficits on tests of
executive function, traditionally considered sensitive to
frontal lobe damage. Such deficits are characterized
Neuron
606Figure 2. The Transgenic D2 Receptors Are
Functional
(A) Saturation ligand binding analysis with the
D2 receptor antagonist [3H]-3-methyl-spiper-
one, using striatal membranes prepared from
D2 transgenic and control littermates.
(B) Saturation ligand binding analysis with
doxycycline-treated mice used in the behav-
ioral experiment of Figure 5A.
(C) Adenylate cyclase activity of striatal mem-
branes from D2R transgenic mice and control
littermates in the absence of dopamine.
(D) Adenylate cyclase activity of striatal mem-
brane extracts in response to increasing con-
centrations of dopamine.
Error bars represent SEM.by impairments in planning, maintenance of goal-di-
rected behavior, working memory, and behavior flexibil-
ity. We therefore tested the mice in two independent de-
layed non-match to sample (DNMTS) maze tasks that
require the mice to integrate information held online
(the sample run) with the learned rule (non-match to
sample).
In the first task, an eight-arm radial maze DNMTS, or
‘‘win-shift,’’ task (Floresco et al., 1997), mice overex-
pressing D2 receptors showed a significant deficit atday 10 when trained with a delay of 60 s (Figure 4A;
two-way ANOVA, multiple comparison post hoc Stu-
dent-Newman-Keuls method, genotype within day 10,
p < 0.025). In the second test, a DNMTS T-maze task
(Dias and Aggleton, 2000), transgenic mice showed im-
paired acquisition of the task using a delay of 4 s. An
equal number of transgenic and control mice reached
a preset criterion within 28 days of training (Figure 4C;
correct choice for 11 out of 12 consecutive trials,
or 92%), but D2 receptor transgenic mice requiredFigure 3. Mice Overexpressing D2 Receptors in the Striatum Do Not Display Hyperlocomotor Activity, Sensory Motor Gating Deficits, or Gen-
eralized Anxiety
(A) Locomotor activity of D2R transgenic mice and control littermates in an open field (day 1). Mice were exposed in an open field for 1 hr while
ambulatory distance was measured. The graphs show the mean ambulatory distance in 5 min bins (n = 17 per group, p > 0.05).
(B) D2 receptor mice show no deficits in sensorimotor gating. Prepulse inhibition of acoustic startle was measured using prepulses with 3, 6, and
12 dB and a pulse of 120 dB (n = 12/10).
(C) D2 receptor mice show normal anxiety levels in the elevated-plus maze. The ratio of open-arm versus closed-arm entries is shown (t test,
p < 0.05, n = 17 per group).
Error bars represent SEM.
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607Figure 4. Mice Overexpressing D2 Receptors in the Striatum Display Deficits in Working Memory Tasks and Behavioral Flexibility
(A) Performance of control and D2R transgenic mice in a radial-arm-based delayed win-shift task using a delay of 60 s. Mice trained for 10 days,
one session per day. Across phase errors (revisits to arms visited before the delay period) are shown. *ANOVA, post hoc Student-Newman-Keuls
comparison, genotype within day 10, p < 0.025).
(B) Performance of control and D2 receptor transgenic mice in a T-maze based DNMTS task using a delay of 4 s. (Left) Days to reach criterion
(t test, p < 0.05, n = 9 per group).
(C) Number of mice reaching criteria after 28 days.
(D) (Left) Performance of ACSF (SHAM) and NMDA (Lesion) injected mice in the DNMTS T-maze task (t test, p < 0.025, n = 9/10 per group).
(E) Schematic representation of the smallest (black) and largest (gray) NMDA-mediated lesion in the dorsomedial PFC (Bregma +2.3 mm to
+0.7 mm).
(F) Performance of D2 receptor and control mice in an odor-discrimination task. Trials to criterion are scored. Day 1, discrimination learning; day
2, discrimination repetition; day 2 rev, reversal of the rule. No differences in accuracy were detected between the groups.
(G) Latency to start digging in the correct bowl. A significantly increased latency in the D2 receptor mice is measured when the rule is reversed,
indicating a mild deficit in flexibility (t test, p < 0.05, n = 14 per group).
(H) The increase in latency disappears in D2 receptor transgenic mice when they have learned the reversed rule. Trial 1–4, latency for the first four
trials of the reversal session (t test, p < 0.05, n = 14 per group). Last 4 trials, latency for the last four trials.
Error bars represent SEM.significantly more trials to reach this criterion (t test,
p < 0.05, n = 9 per group; Figure 4B).
In rats, both of these DNMTS tasks are dependent on
an intact medial PFC (Floresco et al., 1997; Dias and Ag-
gleton, 2000; Lee and Kesner, 2003). To explore the
functional homology between the mPFC in mice and
the mPFC in rats, we lesioned the mPFC of wild-type
mice with N-Methyl-D-Aspartate injections and tested
the mice in the DNMTS T-maze task. We designed theexperiment based on a study by Dias and Aggleton
(2000). This study showed that in rats acquisition of
the DNMTS T-maze task is impaired by larger prefrontal
lesions combining anterior cingulate, prelimbic, and in-
fralimbic cortex, but not by discrete prefrontal lesions
that included only the prelimbic and infralimbic, or the
anterior cingulate cortex. We therefore lesioned the
mPFCofwild-typemice,specificallyaffecting the infralim-
bic, prelimbic, and anterior cingulate cortices, although
Neuron
608Figure 5. Reversal of D2 Receptor Overex-
pression by Doxycycline Does Not Recover
the Deficit in the Working Memory Task
(A) At the age of 90 days, both D2R mice and
control littermates were fed doxycycline to
switch off transgene expression in D2R
mice. Mice were tested in the DNMTS T-
maze task. Days to reach criterion is scored
(t test, p < 0.05, n = 10/9).
(B) At day 28, only 40% of transgenic mice
reached criterion (c2 test, p < 0.05).
(C) Mice were fed with doxycycline at birth
and tested in the DNMTS T-maze task. Days
to reach criterion is scored (t test, controls
on dox versus D2R mice on dox: p < 0.05,
n = 7/7). Doxycycline (40 mg/kg food pellets)
itself does not affect the performance of con-
trol animals in the T-maze DNMS task, even
when applied from birth until adulthood (con-
trols off dox versus on dox, n = 7/7).
(D) At day 28, an equal percentage of mice per
group reached criterion (controls off dox,
controls and D2R mice on dox at P0, n =
7/7/7). (E) Mice overexpressing D2 receptors
do not suffer from a general cognitive deficit.
Performance of control and D2R transgenic
mice in a T-maze spatial reference memory
task. Days to criterion are scored (n = 7 per
group).
(F) Performance of D2 receptor transgenic
and control mice in the Morris water maze.
D2R mice showed normal acquisition of the
visible and the hidden platform task (days 1
and 2 and days 4–7, respectively), as mea-
sured by escape path-lengths.
(G) Morris water maze probe trial. On day 7,
the hidden platform was removed and quad-
rant occupancy measured. D2 receptor
transgenic mice and control littermates
show equal spatial preferences for the target
quadrant (QDT3).
Error bars represent SEM.we affected the infralimbic cortex to a lesser degree than
in the rat study of Dias and Aggleton (Figure 4E).
Lesions significantly increased the number of trials
required to reach criterion (Figure 4D; NMDA: 11.0 6
0.7 days, ACSF: 4.8 6 0.3 days, n = 10/9, p < 0.05) but
did not affect the latencies to solve the task (latencies
day 1 to 7, ANOVA: df = 1, F = 0.28, p = 0.6, data not
shown). This results shows that the mPFC is also re-
quired in mice for performing a DNMTS T-maze task.
Control mice in this experiment performed better than
control mice in other DNMTS T-maze experiments,
most likely because of differences in housing conditions
(see the Supplemental Data available online).
Another form of executive function that is impaired in
schizophrenia is attentional set-shifting and behavioral
flexibility. To test this cognitive domain, we used an at-
tentional set-shifting paradigm that is based on olfac-
tory discrimination (Colacicco et al., 2002; Birrell and
Brown, 2000). The number of trials required to learn
the original odor-reward association, to remember the
association 24 hr later, and to reverse that association
were not affected. However, transgenic mice display
significantly increased latencies to choose between
the two odors during the reversal trials, indicating
a mild deficit in reversal of the rule (Figures 4F–4H; trans-
genic = 72.8 6 12.7s, control = 40.4 6 7.3s, t test,p < 0.05, n = 14 per group). We also tested the mice on
intra- and extradimensional shifts (see Experimental
Procedures) but observed no differences in accuracy
between genotypes (data not shown, n = 9 per group).
Reversal of D2 Receptor Overexpression
by Doxycycline Does Not Reverse
the Cognitive Deficit
To determine whether the behavioral deficits are due to
concurrent dopamine hyperactivity in the striatum or to
chronic or developmental effects of increased striatal D2
receptor function, we fed both adult double-transgenic
mice and control littermates doxycycline (40 mg/kg
food pellets) to switch off transgene expression in D2 re-
ceptor transgenic mice. Two weeks after beginning the
doxycycline administration, we began testing the mice
on the DNMTS T-maze task and found that a significant
increase in the number of trials required to reach criteria
compared to littermates remained (Figure 5A; t test, p <
0.05, n = 9/10 per group). In this same group of mice,
doxycycline administration normalized the binding ca-
pacity of D2 receptor in the striatum of the transgenic
mice (Figure 2B). Thus, the concurrent expression of
transgenic D2 receptors in the adult animal is not re-
sponsible for the cognitive deficit; chronic or develop-
mental expression of the receptors is sufficient to cause
Excess Striatal D2 Receptors Affect PFC Function
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genic mice reaching criteria after 28 days of training
was significantly reduced compared to controls (Fig-
ure 5B; c2 test, p < 0.05, n = 9/10 per group). This sug-
gests that normalizing D2 receptor levels in chronically
overexpressing adults may result in an even more
severe phenotype, although comparison between inde-
pendent behavioral experiments are not fully conclu-
sive. To determine whether developmental overexpres-
sion of D2 receptors alone is sufficient to cause the
behavioral deficit, we switched off transgene expression
at birth. We found that D2 transgenic mice still show the
deficit in the working memory task (Figure 5C; controls
on dox: 12.8–2.4 days, D2 transgenics on dox: 19.57 6
1.67, p < 0.05). An equal number of transgenic and con-
trol mice reached a preset criterion within 28 days of
training (Figure 5D). To see whether doxycycline treat-
ment affects performance in the T-maze task, we also in-
cluded control littermates that were not fed with doxycy-
cline and compared their performance with the control
littermates that were fed with doxycycline. We observed
no effect of doxycycline (Figures 5C and 5D).
Mice Overexpressing D2 Receptors Do Not Suffer
from a General Cognitive Deficit
D2 transgenic mice showed no abnormalities in two dif-
ferent spatial reference memory tasks. We used the
same T-maze apparatus that was used for the DNMTS
task to test the acquisition of a simple spatial rule: the
same arm of the maze was baited on every trial. Both ge-
notypes required the same number of days to reach cri-
terion (11 correct out of 12 trials, Figure 5E; transgenic:
11.4 6 1.7 days, control: 10.0 6 1.5 days, p < 0.53, n =
7 per group). This indicates that the deficit observed in
the DNMTS T-maze cannot be explained by problems
with spatial learning, motivation, food-reward associa-
tions, or a general cognitive deficit. Transgenic mice
also performed normally in both the visible (day 1 and
2, Figure 5F) and invisible platform versions of the Morris
water maze (day 3 to 7, Figure 5F for acquisition and
Figure 5G for probe trial, n = 12 per group).
Mice Overexpressing D2 Receptors in the Striatum
Show Altered Glucose Metabolism in the Striatum
and Cortex
Since D2 transgenic mice show deficits in a prefrontal-
dependent task, we wanted to know whether striatal
D2 receptors indirectly affect the PFC and, if so, how.
We first looked at whether excess striatal D2 receptors
affect basal activity in the PFC through cortico-striatal
loops. We did so by determining basal metabolic activity
in different cortical regions, in the striatum, and in the
hippocampus by measuring the uptake of radiolabeled
2-deoxy-glucose (2-DG).
We found a significant reduction in basal metabolic
activity in the caudate putamen (Figure S1A; t test, p <
0.0003; Bonferroni corrected, p < 0.0039) and significant
increases in the primary motor and somatosensory cor-
tices (t test, p < 0.004; Bonferroni corrected, p < 0.05;
t test, p < 0.007, n = 7 per group). The changes in basal
metabolism are reversed after 2 weeks of doxycycline
intake (Figure S1B) and are therefore unlikely to be re-
sponsible for the cognitive deficits we observed in the
DNMTS T-maze.There Are No Obvious Morphological Changes
in the PFC of Mice Overexpressing D2 Receptors
in the Striatum
Developmental overexpression of D2 receptors could
lead to persistent morphological changes in the PFC,
but examination of Nissl-stained coronal sections (Fig-
ure 6A) did not reveal any major abnormalities in trans-
genic mice.
During embryogenesis, the lateral and medial gangli-
onic eminences (LGE and MGE) give rise to both neo-
striatal neurons and GABAergic neurons in the cortex.
In rats, the cell cycle of neuronal precursors in the LGE
is regulated by dopamine via D1 and D2 receptors (Oh-
tani et al., 2003); we therefore investigated whether
transgenic D2 receptors are expressed during embryo-
genesis and, if so, whether the number of interneurons
in the cortex may be affected by D2 receptor upregula-
tion during development. We performed in situ hybrid-
ization analysis and found that transgenic D2 receptors
are expressed in the striatum at e17.5 (data not shown).
To analyze the density of GABAergic interneurons in the
medial PFC, we performed in situ hybridization with a
riboprobe against the rat glutamate decarboxylate 1
gene. A stereological analysis detected no differences
in the number of GAD67 (GAD1) positive neurons in the
prelimbic cortex between genotypes (Figure 6B; con-
trol = 192.8 6 35.2 cells/mm2, transgenic = 190.7 6
23.5 cells/mm2; t test, p > 0.5, n = 3/4 animals per group).
Mice Overexpressing D2 Receptors Show Normal
Dopaminergic Innervation, but Altered Dopamine
Transmission in the PFC
To determine whether chronic, developmental upregu-
lation of D2 receptors in the striatum affects mesocorti-
cal dopamine projections, we examined the dopaminer-
gic innervation of the PFC in D2 receptor transgenic
mice by quantifying tyrosine hydroxylase (TH)-positive
varicosities in the medial PFC. Stereological analysis re-
vealed no differences in the density of TH-positive termi-
nals (control = 2.67 units/frame, transgenic = 2.63 units/
frame, p = 0.85) or in the density of varicosities per micron
terminal (Figure 6C; control = 0.50, transgenic = 0.53,
p = 0.11, n = 3/3 mice).
To determine whether dopamine transmission in the
PFC is altered by D2 receptor overexpression, we mea-
sured the ex vivo tissue content of dopamine and its me-
tabolites in the medial PFC using HPLC. We found an in-
crease in dopamine levels (F[1,18] = 5.2, p < 0.05) and
a decrease in both the DOPAC:DA ratio (F[1,25] = 9.7,
p < 0.01) and the HVA:DA ratio (F[1,25] = 6.7, p < 0.05),
indicating a decrease in dopamine turnover (Table 1).
Overexpression of D2 Receptors in the Striatum
Affects D1 Receptor Activation in the Medial PFC
In rats, subchronic depletion of dopamine increases the
in vivo binding potential of the D1 ligand [11C] NNC 112 in
the frontal cortex (Guo et al., 2003). Dopamine produces
its modulation of working memory through activating
prefrontal D1 receptors. Therefore, we determined D1
receptor activation in the PFC of transgenic mice by
measuring the induction of the immediate early gene
c-fos by the selective D1 agonist Chloro-APB (Glickstein
et al., 2002). We injected mice i.p. with 1 mg/kg Chloro-
APB, collected their brains after 1 hr, and performed
Neuron
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Activation of D1 Receptors in the Prefrontal
Cortex
(A) Fresh frozen cryostat sections (20 mm)
stained with Nissl (203) revealed no gross dif-
ferences in the PFC. (B) Fresh frozen cryostat
sections (20 mm) were hybridized with a
riboprobe against the rat Gad67 (Gad1)
gene. Stereological analysis revealed no sig-
nificant difference in the density of GAD67-
positive neurons in prelimbic area of the PFC.
(C) There was no significant difference in the
density of tyrosine hydroxylase-positive vari-
cosities (number/mm of terminal).
(D) Induction of c-fos expression in the pre-
limbic cortex 1 hr after injection with the se-
lective D1 agonist (+) SKF-92958 hydrobro-
mide (Chloro-APB hydrobromide). Fresh
frozen cryostat sections (16 mm) were incu-
bated with an antibody to c-fos. Saline and
Cl-APB injected control and D2 receptor
mice are depicted.
(E) Stereological analysis of D1 agonist in-
duced c-fos-positive cells. Relative number
of c-fos-positive cells in the prelimbic cortex
of adult D2 receptor and control animals
(t test, p < 0.005, n = 5 per group).
(F) Relative number of c-fos cells in doxycy-
cline-treated animals (t test, p < 0.005, n = 5
per group).
Error bars represent SEM.stereological analysis of brain sections immunolabeled
for c-fos. We found that the basal c-fos levels of sa-
line-injected animals were not changed in the prelimbic
area of the PFC, whereas after injection of the D1/5 se-
lective agonist 6-Chlor APB a significant increase in
the number of c-fos-positive cells was observed in D2
receptor transgenic mice (Figures 6D and 6E, left; D2
transgenic: 114.5% 6 5.6%, control: 100.0% 65.5%,
p < 0.0035, n = 5/5 mice). To determine whether this
alteration is coincident with D2 receptor overexpres-
sion, we counted c-fos-positive cells in mice that were
fed for 14 days with doxycycline-supplemented food
(40 mg/kg) after reaching adulthood. A genotypic differ-
ence remained, but now in the opposite direction. Trans-
genic mice in which overexpression of D2 receptors was
switched off showed a significant decrease in the num-
ber of c-fos-positive neurons, suggesting that they de-
veloped compensatory processes for D1 receptor func-
tion that are independent of concurrent D2 receptor
Table 1. Tissue Concentrations of Dopamine and Its Metabolites
in the Medial Frontal Cortex
Dopamine HVA DOPAC HVA/DA DOPAC/DA
Control mean 3.79 2.72 0.29 0.84 0.24
std err 0.89 0.69 0.05 0.18 0.07
n 17 17 14 17
D2-R mean 6.68* 2.02 0.35 0.47* 0.14*
std err 1.78 0.35 0.08 0.08 0.06
n 14 14 8 14
* Significant effect of genotype (p < 0.05).function (Figure 6F; transgenic: 88.3% 6 1.7%, control:
100.0%6 3.0%, p < 0.0015, n = 5/4 mice). Since working
memory requires on optimal level of D1 receptor activa-
tion, the increased and decreased activation of D1
receptors in the medial PFC of the nontreated and doxy-
cycline-treated transgenic animals may well be respon-
sible for the deficits in the working memory tasks seen
under both conditions.
To determine whether increased activation of D1 re-
ceptors is due to increased levels of D1 receptors in
the PFC, we measured the mRNA levels and the binding
sites of D1 and D5 receptors in the PFC. Real-time PCR
showed no differences in the amount of D1 and D5 re-
ceptor mRNAs (control/transgenic: D1 MNE = 0.06 6
0.004/0.06 6 0.003, D5 MNE = 0.033 6 0.002/0.034 6
0.002, n = 5/5 mice). Saturating ligand binding studies
with frontal cortical membranes using the D1 antagonist
[3H]-SCH23390 showed no differences between the ge-
notypes (control/transgenic: Bmax = 17.3/21.1 fmol/mg,
p > 0.05, Kd = 0.11/0.07, p > 0.05, n = 5 3 3 mice per
group).
Discussion
To study directly the relationship between increased do-
pamine D2 receptor expression in the striatum and cog-
nitive deficits, we generated mice that allow temporally
controlled overexpression of this receptor in the stria-
tum alone. We found that overexpression of D2 recep-
tors in the striatum leads to specific deficits in behav-
ioral flexibility and in the acquisition of two different
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611working memory tasks. D2 receptor overexpression in
the striatum also leads to increased dopamine levels,
decreased dopamine turnover, and increased D1 recep-
tor activation in the medial PFC, factors which may ex-
plain the behavioral phenotype. The impairment in the
working memory task is not due to the concurrent over-
expression of D2 receptors in the adult animal, because
switching off the excess D2 receptor expression in the
adult animal does not correct the deficit. Rather, the
cognitive deficit may reside in an imbalance in the acti-
vation of D1 receptors in the PFC, secondary to the D2
overexpression in the striatum. This imbalance persists
even after D2 receptors levels are returned to normal.
Overexpression of D2 Receptors in the Striatum
Leads to Deficits in Working Memory Tasks
and Behavioral Flexibility
Based on imaging and lesion studies, working memory
and behavioral flexibility have been generally associated
with the dorso-lateral PFC in humans and nonhuman pri-
mates (Goldman-Rakic, 1994; Fuster, 1997). Anatomical
and lesion studies in rats suggest that the medial PFC is
the homologous structure of the dorso-lateral PFC in
primates (Markowitsch and Pritzel, 1977; Birrell and
Brown, 2000, Fuster, 1997). We show here that the me-
dial PFC is also required for the acquisition of a working
memory task in mice. Thus, excess D2 receptors in the
striatum are not necessarily expected to affect working
memory tasks. However, the striatum participates in
a cortico-striatal-pallido-thalamo-cortical associative
loop (Alexander et al., 1986). In primates, this ‘‘associa-
tive loop’’ includes the dorsolateral PFC, much of the
caudate nucleus, the precommisural putamen, and the
ventral anterior thalamus (Haber, 2003). In rodents,
the analogous associative loop consists of the dorsal
anterior cingulate and prelimbic cortices, the medio-
dorsal striatum, and the central medial and paracentral
thalamic nuclei (Voorn et al., 2004). Perturbing this cir-
cuit at any point may affect its function, and, indeed,
there are studies in primates and rats showing that
dysfunction of the striatum produces similar deficits as
dysfunction of the PFC (Battig et al., 1960; Divac, 1972;
Partiot et al., 1996).
Conceivably therefore, the cognitive impairments in
the striatal D2 receptor-overexpressing mice are due
to the effects of excess D2 receptors on the efficiency
of the cortico-striatal synapses. Alternatively, the striatal
D2 receptors could indirectly affect prefrontal cortical
function. This could happen in two distinct ways, either
through cortico-striatal-thalamo-cortical loops or
through the dopaminergic neurons of the midbrain.
Excess Striatal D2 Transmission Can Contribute
to Abnormal Prefrontal Cortical Function
We found that increased expression of D2 receptors in
the striatum leads to alterations in prefrontal activity,
possibly through the dopaminergic neurons of the mid-
brain. In rats, the neurons of the caudate putamen and
nucleus accumbens project directly or indirectly to the
substantia nigra pars compacta medialis and the ventral
tegmental area that both possess dopaminergic projec-
tions to the PFC (Bunney and Aghajanian, 1976; Lough-
lin and Fallon, 1984; Oades and Halliday, 1987). Measur-
ing dopamine and its metabolite HVA in the frontalcortex, we found increased dopamine levels and de-
creased dopamine turnover. The significant decrease
in dopamine turnover appears to be driven by an in-
crease in intracellular dopamine. While the data clearly
demonstrate a change in the presynaptic component
of the dopamine system in the PFC, they do not allow
for definitive statements about the amount of secreted
or free dopamine. To determine this, studies using in
vivo microdialysis must be performed.
We found that in D2 receptor-overexpressing mice,
activation of c-fos, by a D1 agonist, is increased in the
prelimbic area of the PFC, indicating a higher D1 recep-
tor density or sensitivity. In nonhuman primates and in
rodents, activation of prefrontal D1 receptors affects
working memory, shifting of attentional-sets, and strat-
egy switching (Goldman-Rakic, 1999; Roberts et al.,
1994; Zahrt et al., 1997; Seamans et al., 1998; Granon
et al., 2000). Modulation of working memory by dopa-
mine in the PFC follows an inverted U-shaped function;
too much or too little D1 activation leads to deficits (Sea-
mans and Yang, 2004). Thus, the deficit in the working
memory task in D2 transgenic mice could be explained
by an altered activation of D1 receptors in the PFC.
This increased activation of D1 receptors is probably
not due to increased absolute amounts of D1 receptors
in the mPFC. In fact, using in vitro ligand binding studies
and real-time PCR we did not find evidence for in-
creased D1 receptor expression levels. However, the
observed alterations in dopamine turnover in the
mPFC may affect receptor sensitivity or the externaliza-
tion of D1 receptors to the outer membranes without
necessarily affecting the total amount of receptors
(Guo et al., 2003). Alternatively, D1 receptor activation
by systemic application of Cl-APB may not be altered
in the PFC but in the striatum, which contains the highest
number of D1 receptors in the brain. Altered activation of
the striatum by Cl-APB may then indirectly affect pre-
frontal cortical c-fos activation via the striato-thalamo-
cortical loops.
Switching Off D2 Receptor Overexpression in the
Adult Animal Does Not Reverse the Cognitive Deficit
Despite the normalization of D2 receptor binding and
basal glucose metabolism by switching off the trans-
gene, mutant mice continued to demonstrate the deficit
in the working memory task. If the change in prefrontal
activation of D1 receptors is indeed responsible for the
behavioral deficit, the heightened c-fos response should
remain after D2 receptor normalization. Surprisingly, af-
ter 2 weeks of doxycycline treatment, activation of D1
receptors was decreased in the PFC. Because of work-
ing memory’s U-shaped relation to dopamine transmis-
sion in the PFC, decreased D1 receptor activation fol-
lowing D2 receptor normalization in the striatum could
be responsible for the persistence of the behavioral phe-
notype.
How could these opposing compensatory regulations
arise? One idea would be that during development the
dopaminergic innervation of the cortex is set up in a ho-
meostatic way. Increased D2 receptors in the striatum
may alter the physiology of the dopaminergic midbrain
neurons during development, leading to a new equilib-
rium that may be sensitive to any changes in the adult
animal, such as normalizing excessive receptor levels
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cline.
A Potential Relevance of D2 Overexpression
for Schizophrenia: Steps Toward a Mouse Model
of the Cognitive Endophenotype
Increasing evidence points to a striatal dopaminergic
hyperfunction in schizophrenia. Three studies using ra-
diolabeled D2 receptor-like antagonists found en-
hanced amphetamine-induced dopamine release as
measured by a larger displacement of the radiotracers
in schizophrenic patients compared to controls (Laruelle
et al., 1996; Breier et al., 1997; Abi-Dargham et al., 1998),
implying that amphetamine treatment leads in patients
with schizophrenia to exaggerated dopamine release
and thereby to increased activation of D2 receptors.
Several postmortem and imaging studies have identified
an increase in density of D2 receptors in the striatum.
However, negative findings have also been published,
and the role of D2 increase in the pathophsiology of
schizophrenia remains controversial (for review see Da-
vis et al., 1991; Laruelle, 1998; Seeman and Kapur, 2000).
Measuring D2 receptor density is complicated by the
fact that neuroleptic treatment enhances D2 receptor
expression and different ligands gave different results
in in vivo studies (Seeman and Kapur, 2000). However,
a meta-analysis of 13 in vivo studies by Laruelle (1998)
revealed that D2 receptor density is elevated by about
12% in drug-naive or drug-free schizophrenic patients.
In addition, baseline occupancy of D2 receptors by do-
pamine is enhanced in patients that experience their first
episode and have never been exposed to neuroleptic
treatment (Abi-Dargham et al., 2000).
Other functional imaging studies suggest that the
working memory and cognitive flexibility deficits ob-
served in schizophrenia come from hypofunction of
the frontal cortex, specifically the dorsolateral PFC
(Goldman-Rakic, 1994; Velakoulis and Pantelis, 1996;
Weinberger and Berman, 1996). There also is evidence
for altered dopamine transmission in the PFC (Davis
et al., 1991; Weinberger et al., 1988; Kahn et al., 1994;
Okubo et al., 1997; Akil et al., 1999). One postmortem
study shows decreased TH staining, suggesting a de-
crease in dopaminergic innervation (Akil et al., 1999).
Receptor imaging studies provide disparate results.
One study shows an increase in D1 receptor density in
patients that correlates with impairment in the n-back
working memory task (Abi-Dargham et al., 2002). An-
other study detects a decrease in D1 receptor density
in schizophrenic patients relating to deficits in the Wis-
consin-Card-Sorting task (Okubo et al., 1997). This dis-
crepancy may well be due to the fact that different li-
gands were used in these studies (for discussion see
Guo et al., 2003). Our results obtained with the D2 trans-
genic mice suggest a link between striatal D2 receptors,
prefrontal D1 receptors, and working memory perfor-
mance. Increased density of D2 receptors in the striatum
may lead to working memory deficits by overactivation
of D1 receptors in the PFC.
Hypofunction of the PFC in schizophrenia has been
found to correlate with increased striatal dopamine re-
lease (Meyer-Lindenberg et al., 2002). A prevalent hy-
pothesis holds that alterations in the subcortical dopa-
minergic systems of patients with schizophrenia maybe secondary to a primary hypofunction of the PFC
(Weinberger, 1987; Davis et al., 1991). This hypothesis
was supported by the fact that rodents with PFC lesions
show increased striatal dopamine levels (Jaskiw et al.,
1990). Our results with the D2 transgenic mice suggest
that the opposite causal relationship is also possible:
a primary abnormality of the subcortical dopamine sys-
tem may secondarily affect PFC function. Consistent
with this idea is the observation that in nonhuman pri-
mates neuroleptic treatment downregulates prefrontal
D1 receptors and leads to cognitive deficits that are
re-mediated by treatment with a D1 receptor agonist
(Castner et al., 2000). Future studies should show
whether D1 receptor blockers when applied to the pre-
frontal cortex would reverse the working memory defi-
cits in D2 transgenic mice. In fact, patients with schizo-
phrenia have been treated with D1 antagonists, but with
little success, possibly due to the systemic administra-
tion of the drug.
If increased activation of D2 receptors indeed contrib-
utes to the cognitive deficits of patients with schizophre-
nia, our data could explain why antipsychotics do not
greatly ameliorate cognitive deficits. The physiological
alterations that are responsible for cognitive deficits
may be present long before the first psychotic episode,
when treatment usually commences. Thus, treatment
with typical antipsychotics may be too late to reverse
the physiological alterations that are responsible for
the cognitive deficits.
Rodent models of schizophrenia have significant lim-
itations. The neuronal circuits affected in people are
more complex than the analogous circuits in rodents.
In particular the relative size of the prefrontal cortex
that is involved in the cognitive deficits is much smaller
in rodents than in primates. Some of the cognitive symp-
toms such as hallucinations or delusions are impossible
to address. However, rodent models have the advan-
tage of allowing direct tests of cause-effect relation-
ships for specific aspects of the disease, such as
some of the cognitive deficits. We here have been able
to introduce genetically a single molecular alteration in
a restricted and regulated fashion and study its behav-
ioral and physiological consequences. Given these find-
ings, it is tempting to suggest that the polymorphism in
the D2 receptor gene that increases D2 ligand binding in
the striatum (Lawford et al., 2005; Hirvonen et al., 2004)
may be involved in the etiology of the cognitive symp-
toms.
Experimental Procedures
Generation of Transgenic Mice
The human D2 receptor open reading frame was cloned into the
pMM400 plasmid (Mayford et al., 1996) modified to carry the human
growth hormone poly adenylation sequence instead of the de-
scribed SV40 poly A. The NotI fragment was isolated and used to
generate transgenic mice by injection into pronuclei of one-cell
C57Bl/6-CBA(J) F2 oocytes, which were transferred the next day
via the oviduct into pseudopregnant foster females. Transgenic
founder animals were identified by Southern blots using a probe
specific for the tetO promoter sequence. Progeny of founder ani-
mals were crossed with mice expressing the tTA transgene under
the control of the CamKIIa promoter (Mayford et al., 1996; line B).
Offspring were genotyped by independent Southern blots for tTA
and tetO. For regulating tetO-driven gene expression, mice were
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613fed doxycycline-supplemented chow (40 mg/kg, Mutual Pharma-
ceutical).
In Situ Hybridization
Transgenic expression pattern was determined by in situ hybridiza-
tion using a 42 base anti-sense oligonucleotide specific to the trans-
genic mRNA which overlaps half with the D2 and half with the vector
sequence. For details see the Supplemental Data.
To achieve cellular resolution, we also performed in situ hybridiza-
tion analysis using a digoxigenin-labeled cRNA probe against the
human growth hormone polyA sequence and the rat Gad67 gene
(also named Gad1). DIG in situ hybridization was carried out exactly
as described by Schaeren-Wiemers and Gerfin-Moser (1993).
Saturation Ligand Binding, Adenylate Cyclase Assay
See the Supplemental Data.
Behavior and Data Analysis
For all behavioral tasks, mutant and control littermate males from 3
months of age were used (single transgenic CamKIIa-tTa, tetO-D2R,
and mice carrying neither transgene were pooled together in the
control group, as we saw no effect of single transgene in any exper-
iment). Statistical analyses used ANOVAs with genotype as the be-
tween-subject factor. Mean6 SEM are presented. The experimenter
was blind to the genotype in all studies. Mice were maintained and
bred under standard conditions, consistent with NIH guidelines
and approved by the Institutional Animal Care and Use Committee.
To control for genetic background, we followed the recommenda-
tions made by the Banbury conference on genetic background in
mutant mice (Silva, 1997). TetO-D2 mice were backcrossed four to
six times to the C57Bl/6J background and crossed to CamKII-tTA
mice that were backcrossed 12 to 13 times to the 129SveVTac back-
ground (resulting in a C57Bl/6-129SveV F1 with less than 0.784%–
3.137% of remaining CBA/J background). For details on individual
behavioral procedures, including open field, prepulse inhibition,
elevated plus maze, radial arm maze, T-maze DNMTS, spatial
T-maze, odor discrimination, and the Morris water maze, please
see the Supplemental Data.
Medial PFC Lesions
Mice were anesthetized and injected bilaterally with 0.2 ml of 10 mg/
ml NMDA over 2 min per each of four injection sites. Coordinates
were 2.0 mm and 2.4 mm anterior to Bregma, 0.9 mm lateral to the
midline, and 1.0 mm ventral to the brain surface, the injection needle
was angled at 20º toward the midline. Sham animals received injec-
tions of vehicle (ACSF). Post-surgery, all mice were single housed
and recovered for 2 weeks before testing. After testing, mice were
perfused with 4% PFA, and cryosections of the brain were stained
with Nissl using standard techniques.
14C-2-Deoxyglucose (2-DG) Uptake
See the Supplemental Data.
D1 Agonist c-fos Induction
Mice were injected i.p. with either saline or 1 mg/kg of the D1 agonist
(+) SKF-92958 hydrobromide (Chloro-APB hydrobromide, Sigma).
Exactly 1 hr after injection, the mice were killed by cervical disloca-
tion, brains were removed and quickly frozen in isopentane cooled
to 220ºC on dry ice, stored at 280ºC overnight, and then sectioned
at 16 mm in a cryostat at 220ºC. Sections were thaw mounted onto
Superfrost Plus slides (Fisher) and processed for immunohisto-
chemical staining as described below.
Immunohistochemistry
Standard immunohistochemistry procedures were used for detect-
ing c-fos (rabbit polyclonal anti-c-fos antibody Ab-5; 1:7500; Onco-
gene Sciences, Boston, MA) or tyrosine hydroxylase (mouse Mono-
clonal anti-TH antibody MAB318; 1:5000 Chemicon). For specific
conditions, see the Supplemental Data.
Stereological Analysis
To determine whether the number of nuclei expressing the Fos pro-
tein in the PFC of wild-type and D2 transgenics differed after injec-
tion of saline or the D1 agonist 6-Cholo-APB (see method above)an unbiased stereologic counting method was used. Sections
were examined with a Zeiss Axioscope (Carl Zeiss, Thornwood,
NY) microscope equipped with a motorized stage (Bioprecision
stage coupled with MAC 5000 controller system; Ludl Electronic
Products, Hawthorn, NY) and digital video camera (Digital Video
Camera Company, Austin, TX). This system was interfaced with
a PC-based stereology system (StereoInvestigator by MicroBright-
field, Inc., Colchester, VT). Twenty sections at 80 mm intervals from
Bregma +2.96 to Bregma +1.34 were used from each brain, and
the prelimbic area was defined as in Franklin and Paxinos (1997).
For each experiment, dissector frames and counting grid sizes
were chosen to permit intrasample coefficients of error (CE), calcu-
lated as described previously (Schmitz and Hof, 2000), of less than
5% for both genotypes. For counting c-fos- or GAD67-positive cells,
the optical fractionator method (West et al., 1991) was used. For
counting the density of TH fibers, the L-cycloid optical fractionator
method was used. For determining the density of TH-positive vari-
cosities, the optical fractionator method was used to count varicos-
ities, and the length of fibers in each frame was measured.
Dopamine, DOPAC, and HVA Tissue Content
See the Supplemental Data.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/49/4/603/DC1/.
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